Mammalian target of rapamycin inhibition with enterically given rapamycin alters immunity and gut flora in young and aged wild type mice and extends life of immunodeficient mice (IRC8P.452)
Vincent Hurez(The University of Texas at San Antonio Health Science Center), Tyler J. Curiel(Tulane University), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center), Z. Dave Sharp(Mays Cancer Center at UT Health San Antonio), Vinh Dao(The University of Texas at San Antonio Health Science Center), Justin Drerup(The University of Texas at Dallas), Molly A. Bergman(The University of Texas at San Antonio Health Science Center), Sherry G. Dodds(The University of Texas at San Antonio Health Science Center), Yang Liu(Mudanjiang Medical University), Aijie Liu(The University of Texas Southwestern Medical Center), Álvaro Padrón(Universidade Federal do Rio de Janeiro), Lishi Sun(The University of Texas at San Antonio Health Science Center), Robert S. Svatek(The University of Texas at San Antonio Health Science Center), Srilakshmi Pandeswara(The University of Texas at San Antonio Health Science Center), Paul Hasty(The University of Texas at San Antonio Health Science Center)
Cited by 0
Related Papers
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Interventions to Slow Aging in Humans: Are We Ready?
|Aging Cell|2015|598
Aging and Genome Maintenance: Lessons from the Mouse?
|Science|2003|548